Joe Sutton, global director, sourcing at Eli Lilly and Company, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to serve as officers of DCAT are:  Paolo Magri, senior vice president, business development at Advitech SA as first vice president; Stephan Kutzer, Ph.D., chief executive officer of Alcami Corp., as second vice president; and Sean Diver, director, business development, early intermediates at Lonza, Inc. as third vice president. All will serve one-year terms, effective November 1, 2017.

In addition, the following have been elected to serve one-year terms as directors:
Anita Anderson, senior director, business development, Gyma Laboratories of America, Inc.
Elizabeth Iorns, Ph.D., chief executive officer, Science Exchange
Sally Macaluso, vice president, J&J Business Services Procurement, Johnson & Johnson
Kerri McCullough Wood, senior vice president, head of Commercial, Teva API
Oliver Technow, president, BioVectra, Inc.

Founded in 1890, DCAT is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.